Oxynix FT 27.5 mcg Nasal Spray 120 mdi is indicated for managing the nasal symptoms of seasonal, perennial allergic and non-allergic rhinitis in adult and paediatric patients aged four years and older. Seasonal allergies are caused by exposure to airborne substances (such as pollens) that are only present at specific seasons of the year. Perennial allergies are caused by year-round indoor exposure to airborne pollutants (such as house dust). Perennial non-allergic rhinitis, also known as vasomotor rhinitis, is a chronic illness characterised by symptoms similar to allergic rhinitis (runny nose, stuffy nose, sneezing, and nasal itching) but lasting for more than nine months each year.

Oxynix FT 27.5 mcg Nasal Spray 120 mdi contains fluticasone. Fluticasone works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Thereby, it provides relief from a blocked or runny nose, sneezing, itching, watery eyes and an itchy nose.

Oxynix FT 27.5 mcg Nasal Spray 120 mdi is available on prescription only. Oxynix FT 27.5 mcg Nasal Spray 120 mdi must be taken as directed by the healthcare professional or as per leaflet information to get the maximum benefit of Oxynix FT 27.5 mcg Nasal Spray 120 mdi. With Oxynix FT 27.5 mcg Nasal Spray 120 mdi, very little medicine is absorbed into the rest of the body, so it's not likely to give you side effects. In rare cases, you may experience headaches, nausea, vomiting, sore throat, nose bleeds, trouble breathing, cough, burning, or itching. Most of these side effects of Oxynix FT 27.5 mcg Nasal Spray 120 mdi do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Tell your doctor if you have had an allergic or hypersensitive reaction to fluticasone or other medicines. If you are a pregnant woman or nursing mother, do not consume Oxynix FT 27.5 mcg Nasal Spray 120 mdi without first consulting your doctor. Avoid Oxynix FT 27.5 mcg Nasal Spray 120 mdi use in patients with recent nasal ulcers, surgery, or trauma. It is recommended not to use in children under four years of age. Children aged four years and older can use Oxynix FT 27.5 mcg Nasal Spray 120 mdi under the supervision of a healthcare professional. The development of eye conditions such as cataracts and glaucoma has been reported with the use of fluticasone nasal sprays. You should have a yearly eye exam to check for these conditions. Before using Oxynix FT 27.5 mcg Nasal Spray 120 mdi, please tell your doctor if you have or have ever been treated for fungal, bacterial, viral or parasitic infections. Also, tell your doctor if you have tuberculosis (a type of lung infection).

Insert the tip of the bottle into a nostril while closing the other nostril and spray towards the sides of the nostril. Keep your head straight and breathe gently. Repeat the same process for another nostril.

Oxynix FT 27.5 mcg Nasal Spray 120 mdi contains fluticasone. Fluticasone works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. As a result, it relieves symptoms such as a blocked or runny nose, sneezing, itching, watery eyes, and an itchy nose.

Tell your doctor if you have had an allergic or hypersensitive reaction to fluticasone or other medicines. If you are a pregnant woman or nursing mother, do not consume Oxynix FT 27.5 mcg Nasal Spray 120 mdi without first consulting your doctor, as it will only be prescribed if the benefits overweight the risks. Patients with recent nasal ulcers, surgery, or trauma should avoid using this product. The development of eye conditions such as cataracts and glaucoma has been reported with the use of fluticasone nasal sprays. You should have a yearly eye exam to check for these conditions. Before using Oxynix FT 27.5 mcg Nasal Spray 120 mdi, please tell your doctor if you have or have ever been treated for fungal, bacterial, viral or parasitic infections. Also, tell your doctor if you have tuberculosis (a type of lung infection). The safety and effectiveness in children under the age of four have not been satisfactorily proven. Children aged four years and older can use Oxynix FT 27.5 mcg Nasal Spray 120 mdi under the supervision of a healthcare professional.